FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
FDA approves Isentress at a higher dose for HIV-1 infected patients.
The first generic Truvada for treating and preventing HIV will be available, but when?
FDA has approved the first generic versions of Strattera (atomoxetine) for the treatment of attention deficit/hyperactivity disorder.
FDA approves ribociclib plus letrozole to treat a subset of advanced breast cancer patients.
FDA expanded the use of ivacaftor (Kalydeco, Vertex Pharmaceuticals) to treat cystic fibrosis.
Soon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.